Steven G Coca - Internal Medicine | Mount Sinai

Biography

Specialties

Internal Medicine, Nephrology

Research

Dr. Coca is actively involved in clinical and translational research that focuses on using biomarkers to improve risk-stratification for outcomes in acute and chronic kidney disease. The development of prognostic and predictive biomarkers may aide future clinical trials, by serving as an enrichment strategy for enrollment, and may also serve as outcomes for early phase trials of novel interventions. He has leveraged existing cohorts with banked blood and urine samples, including the ACCORD, VA NEPHRON-D, CANVAS, and DAPA-CKD clinical trials, as well as the Mount Sinai BioMe Biobank and the UPenn Medicine Biobank to explore the prognostic, discriminative, and additional value of biomarkers in AKI and CKD. He has been an active investigator in several large NIH consortia, including the TRIBE-AKI, ASSESS-AKI, CKD Biocon, and Kidney Precision Medicine Project (KPMP). He plans to continue exploring these parameters in other large cohorts and then to design innovative trials employing biomarkers for facilitated enrollment and for better determination of efficacy of existing or new agents.

Education

DO, University of New England College of Osteopathic Medicine

MS, Yale University Graduate School of Arts and Sciences

Residency, Internal Medicine, Yale University School of Medicine

Fellowship, Nephrology, Yale University School of Medicine

Certifications

American Board of Internal Medicine

Honors & Awards

2021

ASN

Midcareer Distinguished Researcher Award

2021

Top Reviewer Award

American Journal of Nephrology

2019

MSIP

“Deal of the Year Award” (for RenalytixAI; shared with Drs. Murphy and Nadkarni)

2018

Stanley L. Cohen Memorial Lecture & Award

Yale New Haven/Bridgeport Hospital Foundation

2017

Joseph R. Renda Memorial Award

Yale University School of Medicine

2013

AFMR 2013 Junior Physician Investigator Award

American Federation for Medical Research

2013

Junior Physician Investigator Award

American Federation for Medical Research

2008

T. Franklin Williams Scholar

2008

K23 Career Development Award

NIH/NIDDK

2008

NIH Loan Repayment Program

NIH

2008

ASN

ASP Junior Development Grant in Geriatric Nephrology

2007

Henry Christian Award

American Federation for Medical Research

2002

Intern of the Year

Yale Primary Care Internal Medicine Program

Midcareer Distinguished Researcher Award,

American Society of Nephrology

Top 5 Reviewer of the Year

Journal of the American Society of Nephrology

Top 5 Reviewer of the Year

Clinical Journal of the American Society of Nephrology

MSIP “Deal of the Year Award”

(for RenalytixAI; shared with Drs. Murphy and Nadkarni)

Top 5 Reviewer of the Year,

Journal of the American Society of Nephrology

Top 5 Reviewer of the Year,

Clinical Journal of the American Society of Nephrology

4D Technology Development Program Award

SINAInnovations

Henry Christian Award

American Federation for Medical Research

Publications

322

Publications

Selected Publications

Using vascular biomarkers to assess heart failure event risk in hospitalized patients with and without AKI. Audrey A. Shi, Anna Simone Andrawis, Aditya Biswas, Francis P. Wilson, Wassim Obeid, Heather Thiessen Philbrook, Alan S. Go, T. Alp Ikizler, Edward D. Siew, Vernon M. Chinchilli, Chi Yuan Hsu, Amit X. Garg, W. Brian Reeves, David K. Prince, Pavan Bhatraju, Steve G. Coca, Kathleen D. Liu, Paul L. Kimmel, James S. Kaufman, Mark W. Wurfel, Jonathan Himmelfarb, Chirag R. Parikh, Sherry G. Mansour. BMC Nephrology

Biomarker Panels for Discriminating Risk of CKD Progression in Children. Jason H. Greenberg, Alison G. Abraham, Yunwen Xu, Jeffrey R. Schelling, Steven G. Coca, Sarah J. Schrauben, F. Perry Wilson, Sushrut S. Waikar, Ramachandran S. Vasan, Orlando M. Gutiérrez, Michael G. Shlipak, Joachim H. Ix, Bradley A. Warady, Paul L. Kimmel, Joseph V. Bonventre, Chirag R. Parikh, Michelle Denburg, Susan Furth, Alison Abraham, Amanda Anderson, Shawn Ballard, Joseph Bonventre, Clary Clish, Heather Collins, Steven Coca, Josef Coresh, Rajat Deo, Michelle Denburg, Ruth Dubin, Harold I. Feldman, Bart S. Ferket, Meredith Foster, Susan Furth, Peter Ganz, Daniel Gossett, Morgan Grams, Jason Greenberg, Orlando M. Gutiérrez, Tom Hostetter, Lesley A. Inker, Joachim Ix, Paul L. Kimmel, Jon Klein, Andrew S. Levey, Joseph Massaro, Gearoid McMahon, Theodore Mifflin, Girish N. Nadkarni, Chirag Parikh, Vasan S. Ramachandran. Journal of the American Society of Nephrology

The Discrepancy Between Estimated GFR Cystatin C and Estimated GFR Creatinine at 3 Months After Hospitalization and Long-Term Adverse Outcomes. Yumeng Wen, Nityasree Srialluri, Danielle Farrington, Heather Thiessen-Philbrook, Steven Menez, Dennis G. Moledina, Steven G. Coca, T. Alp Ikizler, Eddie Siew, Alan Go, Chi yuan Hsu, Jonathan Himmelfarb, Vernon Chinchilli, James Kaufman, Paul L. Kimmel, Amit X. Garg, Morgan E. Grams, Chirag R. Parikh. Kidney International Reports

View All Publications

Video

New Insights into the Diagnosis and Treatment of AKI in Patients with ADHF

Office Locations

Annenberg Building Floor 23 Room 68B

1468 Madison Ave

New York, NY 10029

Annenberg Building Floor 23 Room 68B

1468 Madison Ave

New York, NY 10029

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Coca during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

Bayer Inc.

Founder/Co-Founder/Partner

Renalytix AI, Inc

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Coca during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

Bayer Inc.

Founder/Co-Founder/Partner

Renalytix AI, Inc

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.